Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MDX | TSXV | CAD | Delayed | |
MDX | CBOE Canada | CAD | Real-time |
For the three months ended 31 March 2022, MedX Health Corp. revenues decreased 41% to C$65K. Net loss increased 19% to C$1.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest Exp-Net of Capitalized Interest increase from C$86K to C$247K (expense), Product and software development increase of 26% to C$201K (expense).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 0.06 | 0.21 | 0.09 | 0.26 |
Gross Profit | 0.02 | 0.16 | 0 | 0.12 |
Operating Income | -1.23 | -1.51 | -1.55 | -2.26 |
Net Income | -1.23 | -1.51 | -1.55 | -2.26 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 0.72 | 0.73 | 1.41 | 2.52 |
Total Liabilities | 4.87 | 4.36 | 5.13 | 4.94 |
Total Equity | -4.15 | -3.63 | -3.72 | -2.41 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -0.91 | -4.52 | -3.79 | -2.69 |
Cash From Investing Activities | 0 | -0.02 | -0.01 | -0.01 |
Cash From Financing Activities | 0.86 | 4.6 | 4.46 | 4.47 |
Net Change in Cash | -0.05 | 0.07 | 0.66 | 1.77 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review